ClinVar Miner

Submissions for variant NM_000276.4(OCRL):c.940-11G>A (rs776743373)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000338582 SCV000329445 pathogenic not provided 2017-10-19 criteria provided, single submitter clinical testing The c.940-11 G>A splice site variant in the OCRL gene has been previously reported in association with Lowe syndrome (Hichri et al., 2011; Recker et al., 2015; Montjean et al., 2015; Nakanishi et al., 2017). This pathogenic variant is predicted to lead to the creation of a new cryptic splice acceptor site upstream of the natural splice acceptor site in intron 10, and is expected to lead to abnormal gene splicing. The c.940-11 G>A variant is not observed in large population cohorts (Lek et al., 2016). Functional studies have shown that the c.940-11 G>A results in a significant decrease in both OCRL-1 protein levels and activity in comparison to wild type (Montjean et al., 2015). We interpret c.940-11 G>A as a pathogenic variant.
Pediatric Nephrology (Iijima Lab),Kobe University Graduate School of Medicine RCV000590981 SCV000583551 pathogenic Dent disease type 2; Lowe syndrome 2017-07-13 no assertion criteria provided clinical testing 9 bp of AACTCATAG insertion between Exon 10 and 11 was confirmed by RT-PCR as a result of activating a novel splicing acceptor site by both patient's sample and minigene assay.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.